lysosomal存储疾病的神经表现
Chukwuka Elendu1, Emmanuel A Babawale2, Festus O Babarinde3
1Federal University Teaching Hospital, Owerri, Nigeria.
Annals of medicine and surgery (2012)
|November 11, 2024
概括
溶解体储存疾病 (LSDs) 由于基质的积累导致神经问题. 目前的治疗方法提供有限的逆转大脑损伤,但新的疗法显示出希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 溶酶体储存疾病 (LSD) 是一种罕见的遗传代谢障碍.
- lysosomes 中的基质积累导致多系统性问题,特别是神经系统的参与.
- 中枢神经系统 (CNS) 的影响显著影响患者的生活质量,并带来治疗挑战.
研究的目的:
- 简要介绍一下LSD的神经表现的简要概述.
- 总结关于中枢神经系统参与的基本发现和影响.
- 讨论目前和新兴的LSD治疗策略.
主要方法:
- 关于LSD及其神经影响的当前文献的审查.
- 分析现有的治疗方式及其有效性.
- 讨论管理中枢神经系统参与的挑战和未来方向.
主要成果:
- 神经学表现包括认知障碍,运动功能障碍,发作和感官缺陷.
- 目前的治疗方法主要是控制症状和缓慢进展,在逆转损伤方面取得有限的成功.
- 酶替代,基质减少和基因疗法显示出潜力,但面临诸如血脑屏障透等挑战.
结论:
- 早期诊断,多学科护理和患者倡导对于优化结果至关重要.
- 像基因疗法这样的新兴疗法具有前景,但需要进一步研究有效性和安全性.
- 持续的研究和合作对于推进LSD治疗干预措施至关重要.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomes
16.6K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
16.6K
Inborn Errors of Metabolism
131
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
131


